Sam L. Barker

Director, Lexicon Pharmaceuticals.

Companies

Lexicon PharmaceuticalsBoard member Feb 17, 2006 to now¹
CyclacelBoard member Sep 11, 2014 to Jul 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lexicon Pharmaceuticals LXRX213,771 shares³$352.7K at $1.65Jun 3, 2026
Cyclacel BGMS40,415 shares⁴$36.7K at $0.91Jun 30, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 3, 2026Exercised options 89,312 shares of Lexicon Pharmaceuticals³
May 13, 2025Exercised options 36,810 shares of Lexicon Pharmaceuticals⁵
Apr 28, 2024Exercised options 8,032 shares of Lexicon Pharmaceuticals⁶
Jun 30, 2023Granted 21,219 shares of Cyclacel⁴
May 21, 2023Exercised options 9,302 shares of Lexicon Pharmaceuticals⁷
Jun 14, 2022Granted 15,822 shares of Cyclacel⁸
Apr 30, 2022Exercised options 4,024 shares of Lexicon Pharmaceuticals⁹
Nov 30, 2021Sold 12 shares at $3.57 of Cyclacel¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLexicon Pharmaceuticals, Board member
2
SEC EDGARCyclacel, Board member
3
SEC EDGARLexicon Pharmaceuticals shares after the filing of Jun 3, 2026
4
SEC EDGARCyclacel shares after the filing of Jun 30, 2023
5
SEC EDGARForm 4 filed May 13, 2025
6
SEC EDGARForm 4 filed Apr 29, 2024
7
SEC EDGARForm 4 filed May 22, 2023
8
SEC EDGARForm 4 filed Jun 16, 2022
9
SEC EDGARForm 4 filed May 2, 2022
10
SEC EDGARForm 4 filed Dec 2, 2021